July 26, 2021Open Access

Acalabrutinibe Versus Ibrutinibe em Leucemia Linfocítica Crônica Pré-Tratada: Resultados do Primeiro Ensaio Randomizado de Fase III

Key Points

Key points are not available for this paper at this time.

Abstract

Nesta primeira comparação direta entre inibidores da tirosina quinase de Bruton's menos versus mais seletivos na LLC, o acalabrutinibe demonstrou PFS não inferior com menos eventos adversos cardiovasculares.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

John C. Byrd

Northwestern University

Peter Hillmen

Leeds Teaching Hospitals NHS Trust

Paolo Ghia

Vita-Salute San Raffaele University

Journals

Journal of Clinical Oncology

Actions

Institutions

Cornell University

University of Pennsylvania

The Ohio State University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Acalabrutinibe Versus Ibrutinibe em Leucemia Linfocítica Crônica Pré-Tratada: Resultados do Primeiro Ensaio Randomizado de Fase III

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Also consider